Literature DB >> 8908553

Long term follow-up for patients with liver cirrhosis after partial splenic embolization.

K Murata1, K Shiraki, K Takase, T Nakano, Y Tameda.   

Abstract

BACKGROUND/AIMS: Fifteen cases of liver cirrhosis (LC) were examined to determine whether the partial splenic embolization (PSE), done to improve hematological disorders, could also improve liver function for at least 12 months.
MATERIALS AND METHODS: Peripheral blood count, serological and coagulatory examination were retrospectively examined before PSE, 6 months and 12 months after PSE.
RESULTS: Hematological disorders were improved (p < 0.01) and persisted at improved levels in all cases. In patients in Child A or Child B classification, the levels of cholinesterase, total cholesterol and prothrombin time were also improved significantly after PSE (p < 0.05). However, those parameters were not improved in Child C classification.
CONCLUSION: PSE may improve not only hematological disorders but also liver functions for at least one year.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8908553

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  12 in total

1.  Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenism.

Authors:  Masaki Kato; Naoya Shimohashi; Jiro Ouchi; Kisaku Yoshida; Yuichi Tanabe; Kenji Takenaka; Makoto Nakamuta
Journal:  J Gastroenterol       Date:  2005-11       Impact factor: 7.527

2.  Complications of partial splenic embolization in cirrhotic patients.

Authors:  Takahisa Sakai; Katsuya Shiraki; Hidekazu Inoue; Kazushi Sugimoto; Shigeru Ohmori; Kazumoto Murata; Koujiro Takase; Takeshi Nakano
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

3.  Partial splenic embolization: long-term outcome.

Authors:  Birger Pålsson; Magnus Hallén; Annika Mandahl Forsberg; Anders Alwmark
Journal:  Langenbecks Arch Surg       Date:  2003-01-15       Impact factor: 3.445

4.  Hemodynamic effects of combined therapy using partial splenic embolization and transjugular retrograde obliteration for gastric varices with gastrorenal shunt.

Authors:  Fumio Chikamori; Atsushi Inoue; Hiroshi Okamoto; Nobutoshi Kuniyoshi; Takahiko Kawashima; Yasuhiro Takase
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

5.  Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients.

Authors:  Mahmoud A Amin; Mohamed M el-Gendy; Ibrahim E Dawoud; Ashraf Shoma; Ahmed M Negm; Talal A Amer
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

6.  Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization.

Authors:  Jin-Hua Huang; Fei Gao; Yang-Kui Gu; Wen-Quan Li; Lian-Wei Lu
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

7.  Successful laparoscopic splenectomy after living-donor liver transplantation for thrombocytopenia caused by antiviral therapy.

Authors:  Hiroyuki Kato; Masanobu Usui; Yoshinori Azumi; Ichiro Ohsawa; Masashi Kishiwada; Hiroyuki Sakurai; Masami Tabata; Shuji Isaji
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

8.  Splenic artery embolization as an adjunctive procedure for portal hypertension.

Authors:  Mitchell Smith; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2012-06       Impact factor: 1.513

Review 9.  Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.

Authors:  Massimo Bolognesi; Marco Di Pascoli; Alberto Verardo; Angelo Gatta
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

10.  Partial Splenic Embolization as a Bridge to Total Knee Replacement for a Patient with Severe Thrombocytopenia due to Cirrhosis and Splenic Sequestration.

Authors:  Adrianne Netterville; Ronald Lands
Journal:  Case Rep Hematol       Date:  2012-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.